SCHEMBL10148099

SCHEMBL10148099

C=[N+](C)CCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17993642 0.72
SCHEMBL14759867 0.69
SCHEMBL16711580 0.67
SCHEMBL1062511 0.59 NFKB1 (0.31)
SCHEMBL9721436 0.57 NFKB1 (0.40)
SCHEMBL10510524 0.54
Propylamine SCHEMBL7065649 0.51
Propylamine SCHEMBL15476979 0.51 DNM1 (0.44)
Ethylenediamine SCHEMBL5694570 0.51
Ethylenediamine SCHEMBL987032 0.51 NFKB1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8114870-B2 Method of treating disease states using substituted pyrazole compounds MIIKANA THERAPEUTICS, INC. (US) 2012-02-14 US disclosed
US-20090264422-A1 METHOD OF TREATING DISEASE STATES USING SUBSTITUTED PYRAZOLE COMPOUNDS MIIKANA THERAPEUTICS, INC. 2009-10-22 US disclosed